Core Insights - The event focuses on the latest clinical results from the ophthalmology portfolio presented at ASOPRS and AAO [2] - The agenda includes a 60-minute session with approximately 40 minutes for presentation and 20 minutes for Q&A [3] Company Overview - Bruno Eschli, Head of Investor Relations, introduced the event and highlighted its significance [2] - Nilesh Mehta, the franchise head for ophthalmology and global product strategy, will present on IL-6 development programs in ophthalmology [3]